Skip to main content
Clinical Trials/NCT05820568
NCT05820568
Completed
Not Applicable

Effects and Mechanisms of Change of Two Different Treatments Targeting Worry in Generalised Anxiety Disorder: Study 1 - IU Pilot

Karolinska Institutet1 site in 1 country22 target enrollmentNovember 2, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Generalized Anxiety Disorder
Sponsor
Karolinska Institutet
Enrollment
22
Locations
1
Primary Endpoint
Generalized Anxiety Disorder 7-item (GAD7)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical is to pilot test an internet delivered cognitive behavior therapy (ICBT) based on intolerance of uncertainty (one of several existing specific cognitive models for how worry works) in treating generalised anxiety disorder (GAD). The main aims is to:

  • Test the preliminary effect of the intervention in lowering symptoms of GAD as measured by the self report scale GAD-7
  • Test procedures for recruitment, assessment, treatment and follow up
  • Test the acceptability of the intervention as measured by the Client Satisfaction questionnaire-8, dropout and adverse events

Participants will apply for treatment in an online system, be assessed via video by a licensed clinical psychologist and then receive a 10 week long ICBT intervention based on the intolerance of uncertainty model. This is a pilot study for an upcoming randomized controlled trial.

Registry
clinicaltrials.gov
Start Date
November 2, 2022
End Date
May 22, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erik Forsell

Principal Investigator

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • 18 years old or more.
  • Diagnosis of GAD based on clinical assessment.
  • At least 10 points on GAD-7 at screening.
  • Proficient in written Swedish.
  • Access to internet enabled device and Swedish BankID for authentication
  • Able to make sufficient time for the 10 week long treatment
  • Consents to study

Exclusion Criteria

  • In need of treatment for other psychiatric diagnosis as priority (eg depression, psychosis) or high risk of suicide based on clinical assessment
  • Ongoing risk use of alcohol or drugs
  • Ongoing serious somatic of social disease/problem that is deemed to be to much of a hindrance for the completion of the treatment

Outcomes

Primary Outcomes

Generalized Anxiety Disorder 7-item (GAD7)

Time Frame: 10 weeks after treatment start

Symptoms of generalized anxiety disorder measured by the self report measure GAD7. Scores range from 0-21 with higher scores indicating more generalized anxiety

Secondary Outcomes

  • Treatment credibility(2 weeks into treatment)
  • Satisfaction with treatment(10 weeks after treatment start)
  • Intolerance of uncertainty(10 weeks after treatment start)
  • Symptoms of depression(10 weeks after treatment start)
  • WHO Disability Assessment Schedule (WHODAS 2.0) self report (12 items)(10 weeks after treatment start)
  • Symptoms of depression including suicidal ideation(10 weeks after treatment start)
  • Excessive worry(10 weeks after treatment start)

Study Sites (1)

Loading locations...

Similar Trials